Pazopanib-Associated Transient Ischemic Attack

Am J Ther. 2018 May/Jun;25(3):e393-e394. doi: 10.1097/MJT.0000000000000710.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Angiogenesis Inhibitors / therapeutic use*
  • Female
  • Hemangiosarcoma / drug therapy*
  • Humans
  • Indazoles
  • Ischemic Attack, Transient / chemically induced*
  • Middle Aged
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use*
  • Sulfonamides / adverse effects*
  • Sulfonamides / therapeutic use*
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib